0000917520-24-000023.txt : 20240308 0000917520-24-000023.hdr.sgml : 20240308 20240308162226 ACCESSION NUMBER: 0000917520-24-000023 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240306 FILED AS OF DATE: 20240308 DATE AS OF CHANGE: 20240308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DAVIS ROBERT T. JR. CENTRAL INDEX KEY: 0001563606 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26224 FILM NUMBER: 24734694 MAIL ADDRESS: STREET 1: INTEGRA LIFESCIENCES CORPORATION STREET 2: 311 ENTERPRISE DRIVE CITY: PLAINSBORO STATE: NJ ZIP: 08536 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRA LIFESCIENCES HOLDINGS CORP CENTRAL INDEX KEY: 0000917520 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 510317849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1100 CAMPUS ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6092750500 MAIL ADDRESS: STREET 1: 1100 CAMPUS ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRA LIFESCIENCES CORP DATE OF NAME CHANGE: 19950614 4 1 wk-form4_1709932936.xml FORM 4 X0508 4 2024-03-06 0 0000917520 INTEGRA LIFESCIENCES HOLDINGS CORP IART 0001563606 DAVIS ROBERT T. JR. 1100 CAMPUS ROAD PRINCETON NJ 08540 0 1 0 0 EVP & President, TT 0 Common Stock 2024-03-06 4 M 0 8736 32.585 A 58241 D Common Stock 2024-03-06 4 S 0 8348 36.5946 D 49893 D Non-Qualified Stock Option (right to buy) 32.585 2024-03-06 4 M 0 8736 0 D 2024-03-14 Common Stock 8736 0 D Represents shares sold in connection with a broker-assisted "sell to cover" cashless exercise transaction to cover the exercise price and withholding taxes upon the exercise of stock options scheduled to expire. The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $36.57 to $36.65 The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. 25% of the stock options vested on the first, second, third and fourth anniversary of the original grant date of March 14, 2016. /s/ Eric Schwartz; Attorney-in-Fact 2024-03-08